High-Risk neuroblastoma therapeutics Topotecan and 13-cis-Retinoic acid modulate autophagy and induce DNA damage response in hematopoietic stem cells and monocytes. [PDF]
Lázničková P +5 more
europepmc +1 more source
Treatment Sequencing in Platinum-Resistant Epithelial Ovarian Cancer After MIRASOL, KEYNOTE-B96, and ROSELLA. [PDF]
Liu Y, Xu M, Ma J, Zhu Y, Gao M.
europepmc +1 more source
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma. [PDF]
Han JZR +19 more
europepmc +1 more source
T-Cell Engagers in Lung Cancer: A Comprehensive Literature Review from Tarlatamab Approval to Next-Generation Strategies. [PDF]
Saydawi A +8 more
europepmc +1 more source
Related searches:
Topotecan in the Treatment of Recurrent Small Cell Lung Cancer: An Update
Oncologist, 2004Andrea Ardizzoni
exaly
Topotecan for relapsed small cell lung cancer: A systematic review and economic evaluation
Cancer Treatment Reviews, 2011Andrew Clegg
exaly
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
European Journal of Pharmaceutics and Biopharmaceutics, 2011Marize Campos Valadares +2 more
exaly
Urinary and fecal excretion of topotecan in patients with malignant solid tumours
Cancer Chemotherapy and Pharmacology, 2002Jan H M Schellens +1 more
exaly

